Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (2): 426-430    DOI: 10.31083/j.ceog.2021.02.2260
Case Report Previous articles | Next articles
A giant placental chorioangioma with a resultant live birth; a discussion of management options
Saša Raičević1, *(), Duško Kljakić2, , Filip Vukmirović3, Miloš Z. Milosavljević4
1Clinic of Gynecology and Obstetrics, Clinical Center of Montenegro, University of Montenegro, 81000 Podgorica, Montenegro
2Department of Gynecology, 85000 General Hospital Bar, Montenegro
3Department of Pathology, Clinical Center of Montenegro, University of Montenegro, 81000 Podgorica, Montenegro
4Department of Pathology, University Medical Center Kragujevac, 34000 Kragujevac, Serbia
Download:  PDF(4847KB)  ( 330 ) Full text   ( 33 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Introduction: Chorioangiomas are benign, nontrophoblastic tumors of the placenta. Giant chorioangiomas (larger 5 cm) are infrequent and have unfavorable outcomes due to their strong association with maternal and fetal complications. We describe a case of a giant chorioangioma that had a good outcome without complications. Case report: A 27-year-old woman, primipara, with a regularly monitored pregnancy was admitted to the hospital at 37 + 5 weeks of gestation due to pain in the lower half of the abdomen, rupture of the amniotic sac and accumulation of thick, green, amniotic fluid. Ultrasonography performed at 33 weeks of gestation indicated the presence of a tumor mass 12.5 × 7.7 cm in diameter that was localized near the chorionic surface. Cardiotocography indicated variable decelerations, which necessitated an emergency cesarean section. A live, healthy, male child was born without complications via Dorfler's cesarean section. The encapsulated tumor mass was manually removed from the uterus, and angiomatous chorioangioma of the placenta was diagnosed by pathohistological examination. Conclusion: Ultrasonographic monitoring is the choice method for the accurate diagnosis and intervention of chorioangioma, but only pathohistological examination can confirm the diagnosis. This case report demonstrates that giant placental chorioangioma may have a favorable outcome without any medical intervention.
Key words:  Complications      Placental chorioangioma      Prenatal diagnosis      Color Doppler      Placenta      Tumor      Ultrasonography      Immunohistochemistry     
Submitted:  19 August 2020      Revised:  17 October 2020      Accepted:  21 October 2020      Published:  15 April 2021     
*Corresponding Author(s):  Saša Raičević     E-mail:  sasar@doctor.com
About author:  Dead author.

Cite this article: 

Saša Raičević, Duško Kljakić, Filip Vukmirović, Miloš Z. Milosavljević. A giant placental chorioangioma with a resultant live birth; a discussion of management options. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 426-430.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.02.2260     OR     https://ceog.imrpress.com/EN/Y2021/V48/I2/426

[1] Ryuichi Shimaoka, Tomomi Shiga, Ken-ichirou Morishige. Effect of ritodrine tocolysis on fetal cardiac output distribution to the placenta[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1126-1131.
[2] Mahmoud Alalfy, Soha Talaat Hamed, Alaa Sobhi Abd El Ghani, Ahmed Elgazzar, Amr Abbassy, Ahmed S. S. A. Rashwan, Omar Nagy, Mohamed A Shalaby, Hatem Hassan, Asmaa Ibrahem, Hesham Kamal, Reham Mahrous, Eman Kamal. The accuracy of 3D-TUI and 3D power Doppler using Alalfy simple criteria in the diagnosis of placenta accreta spectrum[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1132-1140.
[3] Anjeza Xholli, Anna Biasioli, Giovanni Grandi, Angelo Cagnacci. Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1186-1192.
[4] Ranit Hizkiyahu, Shannon Salvador, Michael H. Dahan. Ovarian stimulation for fertility preservation in a woman with borderline serous ovarian tumor causing a large fluctuating subcutaneous fluid collection: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(5): 1215-1218.
[5] Silvia Amodeo, Giulia Bonavina, Anna Seidenari, Paolo Ivo Cavoretto, Antonio Farina. Real-world implementation and adaptation to local settings of first trimester preeclampsia screening in Italy: a systematic review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 812-819.
[6] Thanakorn Heetchuay, Thotsapon Trakulmungkichkarn, Noel Pabalan, Nutthaphon Imsom-Somboon. Reference values of fetal atrioventricular time intervals derive from antegrade late diastolic arterial blood flow (ALDAF) from 14 to 40 weeks of gestation[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 867-874.
[7] Mengdie Luo, Junxing Li, Xiaofeng Yang, Qiang Huang, Mengwei Huang, Jie Mei. Intraoperative infrarenal aortic balloon occlusion in pregnancies with placenta accreta spectrum disorder[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 487-493.
[8] Dino Pavoković, Vesna Elveđi Gašparović, Tvrtko Tupek, Analena Gregorić, Ana Tikvica Luetić, Dubravko Habek. Perinatal outcome in twins. A hospital based comparative study at a single third-level care centre in Croatia[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 631-636.
[9] Özgür Koçak, Cem Koçak. Finding the best formulas to estimate fetal weight based on ultrasound for the Turkish population: a comparison of 24 formulas[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 676-685.
[10] Eren Akbaba. Can high transverse skin incision (Modified Maylard) be a new alternative in placenta accreta spectrum management with cesarean hysterectomy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(3): 686-690.
[11] Yu Huang, Fang-Yuan Luo. Clinical efficacy of aortic balloon occlusion during caesarean section in patients with placenta accreta spectrum disorders: a systematic review and meta-analysis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 234-244.
[12] Kumari Anukriti, Kiran Guleria, Vipin Tyagi, Amita Suneja, B D Banerjee. Maternal blood and amnionic oxytocin receptor gene expression and serum oxytocin levels in preterm birth: a case-control study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 283-291.
[13] Ryuichi Shimaoka, Tomomi Shiga, Ken-ichirou Morishige. Change in uterine artery blood flow with intrauterine balloon tamponade[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 307-311.
[14] Xiao-Hua Li, Jian-Kun Zhou, Jing-Dan Cheng. Application of ultrasound in hepatic pregnancy: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 434-438.
[15] Suchaya Luewan, Pakorn Chaksuwat, Tip Pongsuvareeyakul, Theera Tongsong. Prenatal sonographic findings and management of placental mesenchymal dysplasia[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 439-443.
No Suggested Reading articles found!